Cargando…

Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers

Previous studies have reported association of multiple preoperative factors predicting clinically significant prostate cancer with varying results. We assessed the predictive model using a combination of hormone profile, serum biomarkers, and patient characteristics in order to improve the accuracy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faiena, Izak, Kim, Sinae, Farber, Nicholas, Kwon, Young Suk, Shinder, Brian, Patel, Neal, Salmasi, Amirali H., Jang, Thomas, Singer, Eric A., Kim, Wun-Jae, Kim, Isaac Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752561/ https://www.ncbi.nlm.nih.gov/pubmed/29312648 http://dx.doi.org/10.18632/oncotarget.21297

Ejemplares similares

Multimodal treatments for advanced prostate cancer
por: Faiena, Izak, et al.
Publicado: (2019)

Prevention of erectile dysfunction after radiotherapy for prostate cancer
por: Faiena, Izak, et al.
Publicado: (2014)

Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review)
por: FAIENA, IZAK, et al.
Publicado: (2014)

Intracrine androgen biosynthesis in renal cell carcinoma
por: Lee, Geun Taek, et al.
Publicado: (2017)

Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer
por: Farber, Nicholas J., et al.
Publicado: (2018)

Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study
por: Kwon, Young Suk, et al.
Publicado: (2015)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study
por: Kim, Dae Keun, et al.
Publicado: (2018)

Concern for overtreatment using the AUA/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy
por: Kang, Jung Hun, et al.
Publicado: (2014)

Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
por: Movassaghi, Miyad, et al.
Publicado: (2021)

Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer
por: Kim, Isaac E., et al.
Publicado: (2019)

Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations
por: Kim, Isaac E., et al.
Publicado: (2022)

Diagnostic Role of Prostate Resection in the Elderly Patients Who Experience Significant Co-Morbidity with a High Clinical Suspicion of Prostate Cancer
por: Kang, Ho Won, et al.
Publicado: (2013)

Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
por: Kwon, Young Suk, et al.
Publicado: (2021)

Treatment Landscape for Metastatic Castrate-Sensitive Prostate Cancer: A Review
por: Meagher, Margaret F, et al.
Publicado: (2023)

Comparative effectiveness of laparoscopic versus open prostatectomy for men with low-risk prostate cancer: a matched case-control study
por: Parikh, Rahul R., et al.
Publicado: (2017)

Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond
por: Srivastava, Arnav, et al.
Publicado: (2021)

Performing all major surgical procedures robotically will prolong wait times for surgery
por: Shinder, Brian M, et al.
Publicado: (2017)

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era
por: Kim, Isaac E., et al.
Publicado: (2021)

Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documents
por: Shinder, Brian M., et al.
Publicado: (2020)

Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
por: Faiena, Izak, et al.
Publicado: (2018)

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer
por: Lee, Geun Taek, et al.
Publicado: (2019)

WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages
por: Lee, Geun Taek, et al.
Publicado: (2018)

Trends in active surveillance for very low‐risk prostate cancer: do guidelines influence modern practice?
por: Parikh, Rahul R., et al.
Publicado: (2017)

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer
por: Kim, Do-Kyong, et al.
Publicado: (2009)

Prostate Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels
por: Kim, Won Tae, et al.
Publicado: (2011)

Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach
por: Shinder, Brian M., et al.
Publicado: (2017)

Effect of pre-operative internal obturator muscle mass index in MRI on biochemical recurrence of prostate cancer patients after radical prostatectomy: a multi-center study
por: Kim, Won Tae, et al.
Publicado: (2021)

Clinical significance of the De Ritis ratio for detecting prostate cancer in a repeat prostate biopsy
por: Ha, Heon, et al.
Publicado: (2019)

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
por: Kim, Isaac Yi, et al.
Publicado: (2022)

Clinical Significance of Thrombosis in an Intracardiac Blind Pouch After a Fontan Operation
por: Lee, Sang Yun, et al.
Publicado: (2011)

Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer
por: Kim, Jung Kwon, et al.
Publicado: (2016)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

Pre-operative and Post-Operative Alpha Angles are Significant Independent Predictors of Patient-Reported Outcome Measures at Two Years After Hip Arthroscopy
por: Lansdown, Drew A., et al.
Publicado: (2018)

Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy
por: Hong, Jeong Hee, et al.
Publicado: (2017)

Longitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy
por: Kwon, Young Suk, et al.
Publicado: (2018)

Looking to the metabolic landscapes for prostate health monitoring
por: Kim, Wun-Jae, et al.
Publicado: (2017)

Adapting Urology Residency Training in the COVID-19 Era
por: Kwon, Young Suk, et al.
Publicado: (2020)

Pre- and Post-Operative Nomograms to Predict Recurrence-Free Probability in Korean Men with Clinically Localized Prostate Cancer
por: Kang, Minyong, et al.
Publicado: (2014)

AB003. Urinary microRNAs of prostate cancer
por: Kim, Wun-Jae
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r71ef8v8r6cm87q6ltvvuv2p3g